Oruka Therapeutics, Inc. ORKA Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s operating lease liabilities?
- Oruka Therapeutics, Inc. (ORKA) reported operating lease liabilities of $1.13M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s operating lease liabilities changed year-over-year?
- Oruka Therapeutics, Inc.'s operating lease liabilities increased by 69.7% year-over-year, from $664K to $1.13M.
- What is the long-term trend for Oruka Therapeutics, Inc.'s operating lease liabilities?
- Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s operating lease liabilities has grown at a 26.3% compound annual growth rate (CAGR), from $409K to $1.31M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.